Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea.

T. Kinoshita (Chiba, Japan), J. Terada (Chiba, Japan), K. Koshikawa (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan)

Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Session: Diagnostic issues in obstructive sleep apnoea
Session type: Thematic Poster
Number: 817
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kinoshita (Chiba, Japan), J. Terada (Chiba, Japan), K. Koshikawa (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan). Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea.. 817

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Impact of arterial stiffness on variables of Watch-PAT in patients with obstructive sleep apnea.
Source: International Congress 2017 – Diagnostic approaches to obstructive sleep apnoea
Year: 2017

Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016


AutoCPAP devices accurately identify obstructive sleep apnea patients with residual apnea during treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011


Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017


Non-CPAP therapies in obstructive sleep apnoea
Source: Guideline 2011
Year: 2011




Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018




Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008


Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Mixed apnea metrics during diagnostic polysomnographies in obstructive sleep apnea patients with/without treatment-emergent central sleep apnea
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019


Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Impact in adherence to CPAP treatment of a specific consultation for patients with severo obstructive sleep apnoea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Improving adherence to treatment in patients with obstructive sleep apnoea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Comparison of 2 auto-CPAP devices for treatment of obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002